Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591594676> ?p ?o ?g. }
- W2591594676 endingPage "42" @default.
- W2591594676 startingPage "32" @default.
- W2591594676 abstract "Abstract Global prevalence of psoriasis is ranging from 0.91 % to 8.5 % [1]. Exact numbers are missing for Slovakia. 1-5% range is the most probable while 2 % is also mentioned as an average prevalence for the European population. There is approximately 110 thousand patients suffering from psoriasis when extrapolating from total population of 5.5 million [2]. Extracutaneous manifestation is observed in 11–30 % of patients after years of solely skin symptoms presentation [3, 4, 5, 6]. Objective : To estimate prevalence of psoriatic arthritis among psoriatic patients population visiting dermatology out-patient irrelevant of the disease duration and the treatment regimen. To compare the sensitivity of both tests (ToPAS and PASE) used, evaluate possible PsA risk factors. Methods : This was a prospective, non-interventional, epidemiological, observational study conducted using a survey administered to psoriatic patients by their dermatologists. 10–20 consequent outpatients with psoriasis in each center in 43 regional dermatology officies were screened for the presence of extra-cutaneous symptoms (i.e. joint pain, enthesitis, dactylitis, nail involvement) using questionnaire, developed specificaly for this study, and by the PASE and ToPAS questionnaires. Patients without personal history of PsA and „positivity“ of PASE and/or ToPAS were sent to the center for confirmation / exclusion of the diagnosis by applying CASPAR criteria. Outcomes were statistically processed. Results : 177 (21.8 %) of total of 831 psoriatic patients had PsA. 9 of 177 (5.35 %) has been newly diagnosed. There was almost equal number of men (50.5 %) and women (49.5 %). Plaque psoriasis has been most frequent type – 76.9 %. 43.2 % of PsA patients reported the onset of the disease after 40 years of life. Time interval between onset of psoriasis and PsA has been less than 10 years in 20.2 %, 10–20 years in 20.8 % and more than 20 years in 16.1 %. Most frequent co-morbidity in the study population was hypertension 23.2 %, asthma 3 % and diabetes 2.4 %. Average value of BSA and PASI was higher in PsA vs. non-PsA group: 24 vs. 20 and 10 vs 9, respectively. The sensitivity (72.6 % vs 58.9 %, P=0.01) and specificity (81.3 % vs 80.5 %) of ToPAS was higher compared to PASE. Conclusion : 21.8 % PsA prevalence in psoriatic population in Slovakia is within the range observed in other studies. ToPAS test showed comparable results in terms of specificity, but significantly better results in terms of sensitivity and its early application should be of major importance because of the diagnostic process acceleration. The effect of an early diagnosis on the total patient outcome should be an objective of further research. This project was supported from educational grant of Pfizer Inc." @default.
- W2591594676 created "2017-03-16" @default.
- W2591594676 creator A5017502351 @default.
- W2591594676 creator A5066306496 @default.
- W2591594676 creator A5074800671 @default.
- W2591594676 creator A5075566806 @default.
- W2591594676 creator A5076095597 @default.
- W2591594676 creator A5082485815 @default.
- W2591594676 creator A5091253559 @default.
- W2591594676 date "2016-12-01" @default.
- W2591594676 modified "2023-10-06" @default.
- W2591594676 title "Screening of Patients with Psoriasis for Psoriatic Arthritis in the Slovak Republic" @default.
- W2591594676 cites W1683598410 @default.
- W2591594676 cites W1837477529 @default.
- W2591594676 cites W1963627597 @default.
- W2591594676 cites W1966273028 @default.
- W2591594676 cites W1968405676 @default.
- W2591594676 cites W1984910056 @default.
- W2591594676 cites W2006839607 @default.
- W2591594676 cites W2011059902 @default.
- W2591594676 cites W2011656619 @default.
- W2591594676 cites W2012608901 @default.
- W2591594676 cites W2018433361 @default.
- W2591594676 cites W2021018799 @default.
- W2591594676 cites W2022845065 @default.
- W2591594676 cites W2047354818 @default.
- W2591594676 cites W2052383963 @default.
- W2591594676 cites W2067204410 @default.
- W2591594676 cites W2067327580 @default.
- W2591594676 cites W2070132296 @default.
- W2591594676 cites W2072935201 @default.
- W2591594676 cites W2078157933 @default.
- W2591594676 cites W2083180635 @default.
- W2591594676 cites W2083707884 @default.
- W2591594676 cites W2087096065 @default.
- W2591594676 cites W2091677405 @default.
- W2591594676 cites W2099148197 @default.
- W2591594676 cites W2105477284 @default.
- W2591594676 cites W2107730744 @default.
- W2591594676 cites W2108129404 @default.
- W2591594676 cites W2118533896 @default.
- W2591594676 cites W2118619492 @default.
- W2591594676 cites W2122980756 @default.
- W2591594676 cites W2130327929 @default.
- W2591594676 cites W2130501785 @default.
- W2591594676 cites W2137415851 @default.
- W2591594676 cites W2139788459 @default.
- W2591594676 cites W2149095946 @default.
- W2591594676 cites W2152262899 @default.
- W2591594676 cites W2157118376 @default.
- W2591594676 cites W2162507320 @default.
- W2591594676 cites W2343952032 @default.
- W2591594676 cites W2742484040 @default.
- W2591594676 cites W4211046919 @default.
- W2591594676 cites W4211250344 @default.
- W2591594676 cites W4241078057 @default.
- W2591594676 doi "https://doi.org/10.1515/acm-2016-0015" @default.
- W2591594676 hasPublicationYear "2016" @default.
- W2591594676 type Work @default.
- W2591594676 sameAs 2591594676 @default.
- W2591594676 citedByCount "4" @default.
- W2591594676 countsByYear W25915946762018 @default.
- W2591594676 countsByYear W25915946762019 @default.
- W2591594676 countsByYear W25915946762021 @default.
- W2591594676 countsByYear W25915946762023 @default.
- W2591594676 crossrefType "journal-article" @default.
- W2591594676 hasAuthorship W2591594676A5017502351 @default.
- W2591594676 hasAuthorship W2591594676A5066306496 @default.
- W2591594676 hasAuthorship W2591594676A5074800671 @default.
- W2591594676 hasAuthorship W2591594676A5075566806 @default.
- W2591594676 hasAuthorship W2591594676A5076095597 @default.
- W2591594676 hasAuthorship W2591594676A5082485815 @default.
- W2591594676 hasAuthorship W2591594676A5091253559 @default.
- W2591594676 hasBestOaLocation W25915946761 @default.
- W2591594676 hasConcept C107130276 @default.
- W2591594676 hasConcept C126322002 @default.
- W2591594676 hasConcept C16005928 @default.
- W2591594676 hasConcept C23131810 @default.
- W2591594676 hasConcept C2776260265 @default.
- W2591594676 hasConcept C2778019847 @default.
- W2591594676 hasConcept C2780131103 @default.
- W2591594676 hasConcept C2780564577 @default.
- W2591594676 hasConcept C2908647359 @default.
- W2591594676 hasConcept C71924100 @default.
- W2591594676 hasConcept C99454951 @default.
- W2591594676 hasConceptScore W2591594676C107130276 @default.
- W2591594676 hasConceptScore W2591594676C126322002 @default.
- W2591594676 hasConceptScore W2591594676C16005928 @default.
- W2591594676 hasConceptScore W2591594676C23131810 @default.
- W2591594676 hasConceptScore W2591594676C2776260265 @default.
- W2591594676 hasConceptScore W2591594676C2778019847 @default.
- W2591594676 hasConceptScore W2591594676C2780131103 @default.
- W2591594676 hasConceptScore W2591594676C2780564577 @default.
- W2591594676 hasConceptScore W2591594676C2908647359 @default.
- W2591594676 hasConceptScore W2591594676C71924100 @default.
- W2591594676 hasConceptScore W2591594676C99454951 @default.
- W2591594676 hasIssue "3" @default.
- W2591594676 hasLocation W25915946761 @default.